| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE LetPub Score 5.1
50 ratings
Rate
Reputation 6.2 Influence 3.5 Speed 8.5 | ||||||||||||||||
| 期刊簡稱 | ANN DERMATOL VENER | ||||||||||||||||
| ISSN | 0151-9638 | ||||||||||||||||
| h-index | 35 | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| 自引率 (2023-2024) | 9.70%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | http://www.sciencedirect.com/science/journal/01519638 | ||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/ANNDER | ||||||||||||||||
| 開放訪問 | No | ||||||||||||||||
| 出版商 | Elsevier Masson | ||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||
| 出版國/地區 | FRANCE | ||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||
| 創刊年 | 1977 | ||||||||||||||||
| 每年文章數 | 25每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 38.75% | ||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q2
| ||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0151-9638%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||
| 競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE] 的評論 | 撰寫評論 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 11:51:16 評論於 Every study inevitably has its limitations. Factors such as research design and research methods can contribute to these limitations  (0) 讚！ | 维尔娜菲茨杰拉德  |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 11:05:44 評論於 It is still necessary for us to clearly explain the limitations generated in the research in the paper, and to explain how these research limitations will impact the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the research. Discussing the limitations of the research work in the discussion section generally makes the article more credible. Considering how to overcome these limitations in future research will have a positive effect (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 20:41:31 評論於 Do we need to mention the limitations of the article in the discussion? (0) 讚！ | 魂魄彦露 |
| 作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 12:32:25 評論於 What are the limitations of the article? (0) 讚！ | 陶宜三岁啦 |
| 作者: King 領域: 医学 審稿時間: 5.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-10-16 16:40:17 評論於 I was shocked to see this self-introduction rate. Now I still have time to retract the manuscript (0) 讚！ | King |
| 作者: 凌霄友竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-10-16 13:21:06 評論於 When I saw the self-citation rate of this, I was shocked. Is it still possible to withdraw the submission now? (0) 讚！ | 凌霄友竹 |
| 作者: 桃花以柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-09-02 17:06:49 評論於 Can anyone share a website for submissions? I can't find it (0) 讚！ | 桃花以柔 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-07-14 10:40:25 評論於 Anyway, with this bearish appearance, there will be no changes. As long as it doesn't fall, it's fortunate (0) 讚！ | 凌霄高洁 |
| 作者: 西域玉轩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-01-19 17:30:39 評論於 Review speed: 1.0 | Submission success rate: 50.0 Experience sharing: Still in the process of revising, should be able to submit after the New Year (0) 讚！ | 西域玉轩 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
